# Hiroaki Nagano

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hiroaki-nagano/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,676 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 70 |
| i10-index | 309 |
| Last Known Institution | Kyushu University |
| OpenAlex ID | https://openalex.org/A5083677685 |
| ORCID iD | https://orcid.org/0000-0002-7074-3315 |
| Works | 767 |

## Researcher papers

- [Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs](https://scholariq.org/papers/reprogramming-of-mouse-and-human-cells-to-pluripotency-using-mature-micrornas/)
- [CD13 is a therapeutic target in human liver cancer stem cells](https://scholariq.org/papers/cd13-is-a-therapeutic-target-in-human-liver-cancer-stem-cells/)
- [Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma](https://scholariq.org/papers/circulating-microrna-21-as-a-novel-biomarker-for-hepatocellular-carcinoma/)
- [Defined factors induce reprogramming of gastrointestinal cancer cells](https://scholariq.org/papers/defined-factors-induce-reprogramming-of-gastrointestinal-cancer-cells/)
- [Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-s-1-compared-with-observation-in-resected-biliary-tract-cancer-jcog1202/)
- [Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)](https://scholariq.org/papers/randomized-phase-scp-iii-scp-study-of-gemcitabine-cisplatin-plus-s-1-versus/)
- [Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches](https://scholariq.org/papers/combined-intraarterial-5-fluorouracil-and-subcutaneous-interferon-therapy-for/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)

## Researcher university

- [Kyushu University](https://scholariq.org/institutions/kyushu-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.